Validation of the urogenital distress inventory (UDI-6) and incontinence impact questionnaire (IIQ-7) in a Dutch population

Utomo, Elaine; Korfage, Ida J.; Wildhagen, Mark F.; Steensma, Anneke B.; Bangma, Chris H.; Blok, Bertil

doi:10.1002/nau.22496

Cited by 84 publications

(75 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A higher score indicates more impact on daily life of UI. The IIQ-7 has shown to be a reliable, valid, and responsive instrument for assessing the impact on daily life of UI; this also applies for the Dutch version [24] .…”

Section: Secondary Outcomes Subjective Outcome Measurementsmentioning

confidence: 91%

See 1 more Smart Citation

The Effect of Vaginal Oestriol Cream on Subjective and Objective Symptoms of Stress Urinary Incontinence and Vaginal Atrophy: An International Multi-Centre Pilot Study

Weber

Lim

Oryszczyn

et al. 2016

Gynecol Obstet Invest

View full text Add to dashboard Cite

Aim: Subjectively and objectively assess stress urinary incontinence (SUI) symptoms before and after topical oestrogen therapy. Methods: A prospective study was performed in 3 centres in South-Africa, Australia and the Netherlands. Postmenopausal women with SUI were treated with topical oestriol cream for 6 weeks. The primary subjective outcome was the Patient's Global Impression of Improvement (PGI-I) scale. The primary objective outcome was vaginal pH. Secondary subjective outcomes were: the International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form, the Incontinence Impact Questionnaire, the Urogenital Distress Inventory (UDI-6) and the most bothersome symptom approach. Secondary objective outcome was the erect cough pad test. Compliance was scored. Results: A total of 68 women were enrolled. Half of the participants reported improvement on the PGI-I scale after treatment. Vaginal pH was significantly lower after treatment (median 5.3 (interquartile range (IQR) 4.5-6.0) vs. 5.0 (4.4-5.4), p = 0.002). Improvement on the UDI stress domain was observed (p = 0.01). No statistically significant differences were found in the other subjective outcomes. Baseline and repeat cough pad tests demonstrated a wide variation with no significant difference. Compliance was high (median 100 (IQR 83-100%)). Conclusion: Topical oestriol cream during 6 weeks improved quality of life and vaginal pH but no other objective measures of incontinence.

show abstract

Section: Secondary Outcomes Subjective Outcome Measurementsmentioning

confidence: 91%

“…Again, a short version has been developed [23] . The UDI-6 is divided into 3 domains (irritative, stress and obstructive) and has shown to be a reliable, valid and responsive instrument for assessing symptom distress of urinary incontinence, also in the Dutch population [24] .…”

Section: Secondary Outcomes Subjective Outcome Measurementsmentioning

confidence: 99%

The Effect of Vaginal Oestriol Cream on Subjective and Objective Symptoms of Stress Urinary Incontinence and Vaginal Atrophy: An International Multi-Centre Pilot Study

Weber

Lim

Oryszczyn

et al. 2016

Gynecol Obstet Invest

View full text Add to dashboard Cite

show abstract

“…The Urinary Distress Inventory and Incontinence Impact Questionnaire assess symptom distress and the impact on daily life of urinary incontinence. 11 The visual analog scale measured the subjective distress of the patients (scale 0-10). All surgical options, including bulking agents, adjustable balloons, and male sling have been offered to the patients.…”

Section: Methodsmentioning

confidence: 99%

Adjustable Continence Balloons in Men: Adjustments Do Not Translate Into Long-term Continence

Venturino¹,

Dalpiaz²,

Pummer³

et al. 2015

Urology

View full text Add to dashboard Cite

“…Noteworthy, the IIQ-7 also captured small positive changes in female patients with a stable GRS health condition and in male patients with a worsened GRS health condition (although the difference in males was not statistically significant). A validation study in a Dutch population also showed similar findings of small positive changes of the IIQ-7 in patients with stable or worsened health status (Utomo et al 2013). The improvement in patients with worsened health status might be related to the trajectory of health outcomes in LUTS (Revicki et al 2006).…”

Section: Hrqol Measuresmentioning

confidence: 60%

The responsiveness of the International Prostate Symptom Score, Incontinence Impact Questionnaire‐7 and Depression, Anxiety and Stress Scale‐21 in patients with lower urinary tract symptoms

Choi

Chin

Lam

et al. 2015

Journal of Advanced Nursing

View full text Add to dashboard Cite

The International Prostate Symptom Score and Anxiety and Stress subscales were more responsive in males than in females. The symptom questions of the International Prostate Symptom Score and Anxiety and Stress subscales were not externally responsive in females. The health-related quality of life question of the International Prostate Symptom Score outperformed the Incontinence Impact Questionnaire-7 in both males and females, in terms of external responsiveness.

show abstract

Validation of the urogenital distress inventory (UDI-6) and incontinence impact questionnaire (IIQ-7) in a Dutch population

Abstract: The Dutch UDI-6 and IIQ-7 are reliable, valid, and responsive instruments for assessing symptom distress of urinary incontinence and its impact on daily life in both men and women.

Cited by 84 publications

References 36 publications

The Effect of Vaginal Oestriol Cream on Subjective and Objective Symptoms of Stress Urinary Incontinence and Vaginal Atrophy: An International Multi-Centre Pilot Study

The Effect of Vaginal Oestriol Cream on Subjective and Objective Symptoms of Stress Urinary Incontinence and Vaginal Atrophy: An International Multi-Centre Pilot Study

Adjustable Continence Balloons in Men: Adjustments Do Not Translate Into Long-term Continence

The responsiveness of the International Prostate Symptom Score, Incontinence Impact Questionnaire‐7 and Depression, Anxiety and Stress Scale‐21 in patients with lower urinary tract symptoms

Contact Info

Product

Resources

About